Literature DB >> 8452364

Activity of the carbapenem panipenem and role of the OprD (D2) protein in its diffusion through the Pseudomonas aeruginosa outer membrane.

T Fukuoka1, S Ohya, T Narita, M Katsuta, M Iijima, N Masuda, H Yasuda, J Trias, H Nikaido.   

Abstract

Evidence of permeation of panipenem through the OprD (D2) channel of Pseudomonas aeruginosa outer membrane was shown by using OprD protein-producing and -nonproducing strains which contained plasmid pHN4, which codes for L-1 beta-lactamase of Xanthomonas maltophilia. Permeation by panipenem was determined by measuring hydrolysis of the carbapenem by beta-lactamase in the periplasmic space. Permeation by panipenem was also determined by counting uptake of [14C]panipenem into P. aeruginosa PAO1 and its OprD protein-deficient mutant, and this permeation of PAO1 was inhibited by L-lysine. These results indicate that panipenem, as well as imipenem, uses the OprD channel, which functions as a specific channel for diffusion of basic amino acids. Panipenem and imipenem showed stronger activities against PAO1 and clinical isolates in human serum than in Mueller-Hinton broth, which contains more amino acids than human serum does. The activities of the carbapenems were reduced by addition of L-lysine to human serum. Similar results were obtained with mouse serum and ascitic fluid. In contrast, such a change in the activities of carbapenems was not observed with an OprD protein-deficient mutant, suggesting that the main reason for the strong activities of carbapenems in biological fluids is a decrease in competition between the antibiotics and basic amino acids for permeation through the OprD channel. Panipenem and imipenem showed much stronger therapeutic efficacies against experimental infections with P. aeruginosa in mice than did the reference antibiotics. Their in vivo activities were more consistent with their MICs in biological fluids than with those in Mueller-Hinton broth.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8452364      PMCID: PMC187661          DOI: 10.1128/AAC.37.2.322

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  19 in total

1.  Treatment of endocarditis due to Pseudomonas aeruginosa with imipenem.

Authors:  C J Fichtenbaum; M J Smith
Journal:  Clin Infect Dis       Date:  1992-01       Impact factor: 9.079

2.  Ion-exchange chromatography of amino acids in sweat collected from healthy subjects during sauna bathing.

Authors:  P H Gitlitz; F W Sunderman; D C Hohnadel
Journal:  Clin Chem       Date:  1974-10       Impact factor: 8.327

3.  A simple method for the study in vivo of bacterial growth and accompanying host response.

Authors:  S E Day; K K Vasli; R J Russell; J P Arbuthnott
Journal:  J Infect       Date:  1980-03       Impact factor: 6.072

4.  Comparative in vitro activity of N-formimidoyl thienamycin against gram-positive and gram-negative aerobic and anaerobic species and its beta-lactamase stability.

Authors:  H C Neu; P Labthavikul
Journal:  Antimicrob Agents Chemother       Date:  1982-01       Impact factor: 5.191

5.  Porin channels in Escherichia coli: studies with beta-lactams in intact cells.

Authors:  H Nikaido; E Y Rosenberg; J Foulds
Journal:  J Bacteriol       Date:  1983-01       Impact factor: 3.490

Review 6.  Thienamycin: development of imipenen-cilastatin.

Authors:  F M Kahan; H Kropp; J G Sundelof; J Birnbaum
Journal:  J Antimicrob Chemother       Date:  1983-12       Impact factor: 5.790

7.  In-vitro and in-vivo antibacterial activity of imipenem against clinical isolates of bacteria.

Authors:  S Mitsuhashi
Journal:  J Antimicrob Chemother       Date:  1983-12       Impact factor: 5.790

8.  Postantibiotic effect of imipenem on Pseudomonas aeruginosa.

Authors:  C I Bustamante; G L Drusano; B A Tatem; H C Standiford
Journal:  Antimicrob Agents Chemother       Date:  1984-11       Impact factor: 5.191

9.  Permeability of Pseudomonas aeruginosa outer membrane to hydrophilic solutes.

Authors:  F Yoshimura; H Nikaido
Journal:  J Bacteriol       Date:  1982-11       Impact factor: 3.490

10.  Imipenem therapy of Pseudomonas aeruginosa and other serious bacterial infections.

Authors:  D J Winston; M A McGrattan; R W Busuttil
Journal:  Antimicrob Agents Chemother       Date:  1984-11       Impact factor: 5.191

View more
  18 in total

1.  Phenotypic heterogeneity enables uropathogenic Escherichia coli to evade killing by antibiotics and serum complement.

Authors:  Marta Putrinš; Karin Kogermann; Eliisa Lukk; Markus Lippus; Vallo Varik; Tanel Tenson
Journal:  Infect Immun       Date:  2015-01-05       Impact factor: 3.441

Review 2.  Panipenem/betamipron.

Authors:  Karen L Goa; Stuart Noble
Journal:  Drugs       Date:  2003       Impact factor: 9.546

3.  In vitro and in vivo antibacterial activities of SM-216601, a new broad-spectrum parenteral carbapenem.

Authors:  Yutaka Ueda; Katsunori Kanazawa; Ken Eguchi; Koji Takemoto; Yoshiro Eriguchi; Makoto Sunagawa
Journal:  Antimicrob Agents Chemother       Date:  2005-10       Impact factor: 5.191

Review 4.  Carbapenems: past, present, and future.

Authors:  Krisztina M Papp-Wallace; Andrea Endimiani; Magdalena A Taracila; Robert A Bonomo
Journal:  Antimicrob Agents Chemother       Date:  2011-08-22       Impact factor: 5.191

5.  OmpA is the principal nonspecific slow porin of Acinetobacter baumannii.

Authors:  Etsuko Sugawara; Hiroshi Nikaido
Journal:  J Bacteriol       Date:  2012-05-25       Impact factor: 3.490

6.  Metal accumulation and vanadium-induced multidrug resistance by environmental isolates of Escherichia hermannii and Enterobacter cloacae.

Authors:  A Hernández; R P Mellado; J L Martínez
Journal:  Appl Environ Microbiol       Date:  1998-11       Impact factor: 4.792

7.  Transient carbapenem resistance induced by salicylate in Pseudomonas aeruginosa associated with suppression of outer membrane protein D2 synthesis.

Authors:  Y Sumita; M Fukasawa
Journal:  Antimicrob Agents Chemother       Date:  1993-12       Impact factor: 5.191

8.  Genetic definition of the substrate selectivity of outer membrane porin protein OprD of Pseudomonas aeruginosa.

Authors:  H Huang; R E Hancock
Journal:  J Bacteriol       Date:  1993-12       Impact factor: 3.490

9.  Structure-activity relationships of carbapenems that determine their dependence on porin protein D2 for activity against Pseudomonas aeruginosa.

Authors:  J C Fung-Tomc; E Huczko; J Banville; M Ménard; B Kolek; E Gradelski; R E Kessler; D P Bonner
Journal:  Antimicrob Agents Chemother       Date:  1995-02       Impact factor: 5.191

10.  Activity of carbapenem BMS-181139 against Pseudomonas aeruginosa is not dependent on porin protein D2.

Authors:  J C Fung-Tomc; E Gradelski; B Kolek; B Minassian; M Pucci; R E Kessler; D P Bonner
Journal:  Antimicrob Agents Chemother       Date:  1995-02       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.